Head-to-head · free

Eton Pharmaceuticals, Inc. vs Hims & Hers Health

ETON vs HIMS — return on capital, cash generation, margins and balance sheet side by side.

ETON

1 / 7

measures where ETON leads

HIMS

6 / 7

measures where HIMS leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureETON · FY2025HIMS · FY2025
Revenue$80.0M$2.3B
Net income(4.6M)$128.4M
Revenue growth (yearly, multi-year)38.3%71.4%
Free cash flow$10.2M—
Free cash flow margin12.7%—
Net cash / (debt)——
ROIC——
Return on equity-18.2%25.2%
Gross margin53.5%73.8%
Operating margin-1.1%4.5%
Net debt / EBITDA1.44x4.65x

Figures are as reported by each company; latest fiscal year shown.

Where Eton Pharmaceuticals, Inc.'s cash went (FY2025)

Capital spending
$333000
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full ETON profile →

Where Hims & Hers Health's cash went (FY2025)

Capital spending
—
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full HIMS profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons